- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The use of driving impairing medicines: a European survey ; volume:65 ; number:11 ; day:21 ; month:7 ; year:2009 ; pages:1139-1147 ; date:11.2009
European journal of clinical pharmacology ; 65, Heft 11 (21.7.2009), 1139-1147, 11.2009
- Creator
-
Ravera, Silvia
Hummel, Sylvia A.
Stolk, Pieter
Heerdink, Rob E.
de Jong–van den Berg, Lolkje T. W.
de Gier, Johan J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-009-0695-7
- URN
-
urn:nbn:de:101:1-2023050302391019222278
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ravera, Silvia
- Hummel, Sylvia A.
- Stolk, Pieter
- Heerdink, Rob E.
- de Jong–van den Berg, Lolkje T. W.
- de Gier, Johan J.
- SpringerLink (Online service)
Other Objects (12)
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey
Traditional medicines as a mechanism for driving research innovation in Africa
Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
Nurse prescribing of medicines in 13 European countries
The European Innovative Medicines Initiative: Progress to Date
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Uptake of new antidiabetic medicines in 11 European countries
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Impairing hydrolase transport machinery prevents human melanoma metastasis
Factors Driving Wealth Inequality in European Countries
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey
Traditional medicines as a mechanism for driving research innovation in Africa
Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
Nurse prescribing of medicines in 13 European countries
The European Innovative Medicines Initiative: Progress to Date
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Uptake of new antidiabetic medicines in 11 European countries
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Impairing hydrolase transport machinery prevents human melanoma metastasis
Factors Driving Wealth Inequality in European Countries
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey
Traditional medicines as a mechanism for driving research innovation in Africa
Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
Nurse prescribing of medicines in 13 European countries
The European Innovative Medicines Initiative: Progress to Date
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Uptake of new antidiabetic medicines in 11 European countries
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Impairing hydrolase transport machinery prevents human melanoma metastasis